The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu vaccine.According to CNN, HSS on Friday, January 17, 2025, announced that it will award $590 million to Moderna to resume

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines.

The United States government has allocated $590 million to Moderna to develop a vaccine for avian influenza, part of an initiative to address the increasing

With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health officials are preparing for the potential of the virus adapting to enable human-to-human transmission.

Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.

Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of

Funding will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza

The U.S. Department of Health and Human Services (HHS) revealed a major $590 million investment in Moderna to accelerate the development of a bird flu vaccine.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, alongside other influenza vaccines, health officials announced Friday.

U.S. Department of Health and Human Services announced an investment of $590 million in Moderna for the development of a bird flu vaccine.